aph-1 encodes one of the four essential components of the gamma secretase complex, which is essential for Notch signaling.
aph-1 null mutations cause fully penetrant maternal-effect embryonic lethality and egg laying defect. The leaky
aph-1(
zu147) mutation does not compromise egg laying and causes a less severe defect in embryogenesis in which 1% of the embryos survive to adulthood. The
aph-1(
zu147) mutation introduces a stop codon 33 residues prematurely. We have found that this mutant mRNA is destabilized by nonsense-mediated mRNA (NMD) decay. Interrupting NMD with a smg mutation increases mRNA levels of
aph-1(
zu147), and allows for successful embryogenesis in virtually all embryos. This result suggests that it is the decreased levels of
aph-1 activity that are the cause of failed Notch signaling in the embryos from
aph-1(
zu147) mutant hermaphrodites. We have identified two different extragenic suppressors of
aph-1(
zu147) that do not appear to act on mRNA levels, but may instead regulate protein stability through ubiquitin-mediated proteosomal degradation. One of the suppressors encodes a novel gene product that interacts with an E3 ubiquitin ligase, and the other may itself function as an E3 ubiquitin ligase. We do not yet know whether the relevant target protein of these suppressors is APH-1 itself, or other components of the Notch signaling pathway. To this end we have investigated the ability of these suppressors to influence Notch signaling in worms that have compromised Notch receptors or compromised LAG-1, the downstream transcritption effector of the Notch signaling pathway. At least one of the suppressors can influence GLP-1 activity in embryos as well as in gonads, but has no significant effect on LIN-12 function during vulval morphogenesis. Ubiquitin-mediated degradation of Notch receptor and presenilin have previously been demonstrated for the E3 ubiquitin ligase SEL-10, which itself was identified as a suppressor/enhancer of LIN-12 (Hubbard et al., 1997, Wu et al., 2001, Li et al, 2002). We have found that the
sel-10(
n1077) missense mutation (Jager et al, 2004) can partially suppress
aph-1(
zu147) embryonic lethality, suggesting that elevation of Notch and/or presenilin may overcome the
aph-1(
zu147) defect, or that SEL-10 E3 ubiquitin ligase might also target APH-1. We are investigating whether our two suppressor genes act in the same, or in distinct pathways as that of the SEL-10 E3 ubiquitin ligase to modulate embryonic Notch signaling.